Fiest K, Sauro K, Wiebe S, Patten S, Kwon C, Dykeman J, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017;88:296–303.

Article  PubMed  PubMed Central  Google Scholar 

Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020;54(2):185–91.

Article  PubMed  Google Scholar 

Fisher R, Acevedo C, Arzimanoglou A, Bogacz A, Cross J, Elger C, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82.

Article  PubMed  Google Scholar 

Kopczynska M, Zelek W, Vespa S, Touchard S, Wardle M, Loveless S, et al. Complement system biomarkers in epilepsy. Seizure. 2018;60:1–7.

Article  PubMed  Google Scholar 

Perucca P, Bahlo M, Berkovic S. The genetics of epilepsy. Annu Rev Genom Hum Genet. 2020;21:205–30.

Article  CAS  Google Scholar 

Sills G, Rogawski M. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology. 2020;168: 107966.

Article  CAS  PubMed  Google Scholar 

De Vries E, Munckhof B, Braun K, Royen-Kerkhof A, De Jager W, Jansen F. Inflammatory mediators in human epilepsy: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2016;63:177–90.

Article  PubMed  Google Scholar 

Liguori C, Romigi A, Izzi F, Placidi F, Nuccetelli M, Cordella A, et al. Complement system dysregulation in patients affected by idiopathic generalized epilepsy and the effect of antiepileptic treatment. Epilepsy Res. 2017;137:107–11.

Article  CAS  PubMed  Google Scholar 

Flammer J, Neziraj T, Rüegg S, Pröbstel A. Immune mechanisms in epileptogenesis: update on diagnosis and treatment of autoimmune epilepsy syndromes. Drugs. 2023;83(2):135–58.

Article  PubMed  PubMed Central  Google Scholar 

Marchi N, Granata T, Janigro D. Inflammatory pathways of seizure disorders. Trends Neurosci. 2014;37(2):55–65.

Article  CAS  PubMed  Google Scholar 

Propson N, Gedam M, Zheng N. Complement in neurologic disease. Annu Rev Pathol. 2021;16:277–98.

Article  CAS  PubMed  Google Scholar 

McGeer P, Lee M, McGeer E. A review of human diseases caused or exacerbated by aberrant complement activation. Neurobiol Aging. 2017;52:12–22.

Article  CAS  PubMed  Google Scholar 

Zavala-Tecuapetla C, Cuellar-Herrera M, Luna-Munguia H. Insights into potential targets for therapeutic intervention in epilepsy. Int J Mol Sci. 2020;21(22):8573.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fisher R, Cross H, French J, Higurashi N, Hirsch E, Jansen F, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522–30.

Article  PubMed  Google Scholar 

Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WG, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis. 2007;26(3):497–511.

Article  CAS  PubMed  Google Scholar 

Jamali S, Salzmann A, Perroud N, Ponsole-Lenfant M, Cillario J, Roll P, et al. Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures. PLoS ONE. 2010;5(9):1–8.

Article  Google Scholar 

Hincal F, Başaran N, Kansu E, Ciğer A. Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients. Int J Immunopharmacol. 1994;16(12):1071–7.

Article  PubMed  Google Scholar 

Moreno-Ancillo A, Cosmes Martín PM, Domínguez-Noche C, Martín-Núñez G, Fernández-Galán MA, López-López R, et al. Carbamazepine induced transient monoclonal gammopathy and immunodeficiency. Allergol Immunopathol. 2004;32(2):86–8.

Article  CAS  Google Scholar 

Ichiyama T, Okada K, Lipton JM, Matsubara T, Hayashi T, Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappa. Brain Res. 2000;857(1–2):246–51.

Article  CAS  PubMed  Google Scholar 

Da Costa M, Poppelaars F, van Kooten C, Mollnes TE, Tedesco F, Würzner R, et al. Age and sex-associated changes of complement activity and complement levels in a healthy Caucasian population. Front Immunol. 2018;9:2664.

Article  Google Scholar 

Kharatishvili I, Shan ZY, She DT, Foong S, Kurniawan ND, Reutens DC. MRI changes and complement activation correlate with epileptogenicity in a mouse model of temporal lobe epilepsy. Brain Struct Funct. 2014;219(2):683–706.

Article  CAS  PubMed  Google Scholar 

Vezzani A, Friedman A. Brain inflammation as a biomarker in epilepsy. Biomark Med. 2011;5(5):607–14.

Article  CAS  PubMed  Google Scholar 

Mukhtar I. Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: from pathogenesis to treatment target. Seizure. 2020;82:65–79.

Article  PubMed  Google Scholar 

Dalakas MC, Alexopoulos H, Spaeth PJ. Complement in neurological disorders and emerging complement-targeted therapeutics. Nat Rev Neurol. 2020;16(11):601–17.

Article  PubMed  PubMed Central  Google Scholar